INDIANAPOLIS, Nov. 20, 2015 /PRNewswire/ -- Eli Lilly and
Company (NYSE: LLY) today announced it will host a meeting for the
investment community, including institutional investors, sell-side
analysts, ratings agency representatives, and financial and
business media.
The meeting will take place Tuesday,
December 8, 2015, from 9:00 a.m.
(EST) until approximately 4:00
p.m., at the Four Seasons Hotel in Boston.
In the meeting, company leaders will provide an overview of
Elanco, Lilly's animal health business, and present a comprehensive
survey of the company's Alzheimer's disease research program. There
will be Q&A opportunities throughout the meeting.
"We look forward to providing details on two key areas of focus
for our company, animal health and Alzheimer's disease," said
John C. Lechleiter, Ph.D., Lilly's
chairman, president and chief executive officer. "We will review
Elanco's strategy and its growth prospects. Since the acquisition
of Novartis Animal Health in January, Elanco has emerged as a
top-tier animal health company. In addition, investors can expect
to learn more about Lilly's broad research efforts aimed at
improving the diagnosis and treatment of Alzheimer's disease."
A live webcast of the Lilly investment community meeting, along
with presentation slides, will be available through a link on the
investor section of Lilly's website at https://investor.lilly.com/.
The webcast will be available for replay over the next 12
months.
Media interested in attending in person should contact
Lauren Zierke at (317) 277-6524.
Investors interested in attending should contact Edward Villacorta at (317) 433-1805.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with
discovery to make life better for people around the world. We were
founded more than a century ago by a man committed to creating
high-quality medicines that meet real needs, and today we remain
true to that mission in all our work. Across the globe, Lilly
employees work to discover and bring life-changing medicines to
those who need them, improve the understanding and management of
disease, and give back to communities through philanthropy and
volunteerism. To learn more about Lilly, please visit us at
www.lilly.com and newsroom.lilly.com/social-channels.
(C-LLY)
Refer to: Lauren Zierke;
lauren_zierke@lilly.com; 317-277-6524 (Media)
Phil
Johnson; johnson_philip_l@lilly.com; 317-655-6874
(Investors)
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lilly-to-provide-detailed-review-of-elanco-animal-health-and-alzheimers-rd-strategy-at-investment-community-meeting-300182521.html
SOURCE Eli Lilly and Company